Navigation Links
New Smartphone App Launches for Cardiac Imaging Test

PHILADELPHIA, Sept. 24 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for smartphones. The app is designed to give physicians access to published criteria used to assess the need for a patient to have cardiac radionuclide imaging (RNI). The app will be available for free download on the iPhone®, BlackBerry® and Android™ platforms.

The Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging app was adapted from the ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging (RNI) published in 2009 in Circulation. The AUC for RNI describes 67 individual patient indications, eight indication categories, and five algorithms.

The app guides physicians step-by-step through the criteria to evaluate patient history, clinical factors, and other important information to receive an instant appropriate use score for RNI. By entering information, physicians will receive a rating on a scale of 1-9 suggesting if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3) for RNI. Ratings can be viewed either by indication/category or patient algorithm.

According to the annual "Taking the Pulse" study of physicians and healthcare technology released in April 2010, 72% of physicians use smartphones personally and professionally, with that number expected to jump to 81% in 2012.

"Astellas recognizes physicians are increasingly using smartphones and apps in the healthcare setting to access information," said Robert C. Hendel, MD, FACC, FAHA, FASNC, and Chair of the Cardiac Radionuclide Imaging Writing Group that developed the 2009 AUC for RNI. "We partnered with them to develop this accurate, timely, assessment tool for use on smartphones and hope this app will promote awareness and use of the AUC for RNI published in 2009," Dr. Hendel continued.

A preview and interactive demonstration of the app will take place tonight in conjunction with ASNC 2010: The 15th Annual Scientific Session of the American Society of Nuclear Cardiology in Philadelphia. More information and download instructions can be accessed online at


These criteria may provide guidance for clinicians, and are not intended to serve as substitutes for sound clinical judgment and practice experience, nor do they provide information regarding the technical aspects of imaging or delineate training/performance requirements. Additionally, they are not intended to serve as any indication (either approval or denial) of medical insurance coverage for the described tests. The content or material provided is for informational purposes only and should not be construed as medical, legal, financial, investment, or other professional advice or opinion.

About Astellas

The Astellas culture and brand is committed to building community, helping others, encouraging integrity, and inspiring people to make a difference, today, tomorrow, and every day. Astellas Pharma US, Inc., located in Deerfield, Illinois, is a US affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Anti-Infectives, Cardiology, Dermatology, Neuroscience, Transplant, and Urology. For more information about Astellas Pharma US, Inc., please visit our Web site at and follow us on Twitter @AstellasUS.

iPhone is a legal trademark of Apple Inc, registered in the US and other countries.

BlackBerry® and related trademarks, names and logos are the property of Research In Motion Limited and are registered and/or used in the US and countries around the world. Used under license from Research In Motion Limited.

Android is a trademark of Google Inc. Use of this trademark is subject to Google Permissions.

SOURCE Astellas Pharma US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Good Medicine: Smarter Smartphones for People With Chronic Disease
2. Elsevier Launches International Journal of Surgery Case Reports
3. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
4. Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company
5. Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
6. Roche Launches New Initiative - Roche Goes to Town
7. Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill
8. Olympus Launches 2011 National Innovation Awards Program
9. Access Pharmaceuticals Launches MuGard Product Website
10. iFuse Implant System™ Launches at Eurospine
11. PharmaPendium(TM) Launches Pharmacokinetics Module
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015 Next week, December 2-3, ... Things (DoT ) co-located events covering the latest in ... of Things, will draw more than 3,000 design industry ... Convention Center. The events, combined show floor will host ... --> --> BIOMEDevice ...
(Date:11/30/2015)... global cell culture market is expected to grow ... 2022 at a CAGR of 7.1% therein. --> global ... value of US$6.1 bn to US$11.3 bn by 2022 at a ... announced the release of a new market research study, detailing the ... Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation ... cancer education and prevention—is joining forces with the award-winning creator and writer of ... on December 7, 2015 at the Union League of Philadelphia. , The ...
(Date:11/30/2015)... ... , ... The American Society for Clinical Pathology (ASCP) announced today that it ... Nov. 30, ASCP shared its “Give a minute. Get tested. Find a cure.” icon ... of getting tested for HIV. , ASCP has asked members to replace their Facebook, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... ... November 30, 2015 , ... According ... Hansen, Ph.D., a senior scientist at Consumer Reports as supporting a “A Call ... child’s exposure limits. , The original Nov 2015 CR story titled, “Does Cell-Phone ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... last 15 years, announced today that Michigan-based Family Health Center (FHC) has selected ... over 45 years, FHC was awarded the largest Affordable Care Act grant for ...
Breaking Medicine News(10 mins):